#3757
Subtype-specific landscape of splicing-associated neoantigens and mutations in pancreatic neuroendocrine tumors
Introduction:
In pancreatic neuroendocrine tumors (PanNETs), there has recently been advancement in understanding the heterogeneity (metastases-like primary; MLP-1/2, intermediate, and insulinoma subtypes) and immunological landscapes. Immunotherapies provide modest therapeutic benefits to patients, which may be linked to low mutational neoantigen loads in PanNETs.
Conference:
Presenting Author:
Sadanandam A
Authors:
Sadanandam A,
Lawlor R,
Larkeryd A,
Mahalingam A,
Mafficini A,
Keywords:
Pancreatic neuroendocrine tumor,
isoform switching,
subtype,
mutation,
neoantigens,
splice variant,
spliceosomal mutation,
immunotherapy,
immunosuppression,
#930
Distinct Expression of Splicing Variants of the Human MEN1 (Multiple Endocrine Neoplasia Type 1) Gene in Various Pituitary Adenomas
Introduction:
MEN1 is an autosomal-dominant tumor syndrome characterized by the occurrence of tumors in multiple endocrine tissues, including parathyroid, enteropancreatic neuroendocrine and anterior pituitary. The MEN1 gene consists of 10 exons transcribed into a 610 a.a. protein. It was reported that heterogeneity of human MEN1 gene transcripts related to variation in their 5’ UTR. Six distinct exsons1 (e1A-e1F) were isolated using RNA from thymus, pancreas and kidney.
Conference:
11th Annual ENETSConcerence (2014)
Presenting Author:
Ozawa A
Authors:
Ozawa A,
Watanabe T,
Tosaka M,
Yoshimoto Y,
Horiguchi K,
Keywords:
MEN1,
pituitary,